IDO1 Inhibitor RY103 Suppresses Trp-GCN2-Mediated Angiogenesis and Counters Immunosuppression in Glioblastoma

IDO1 Inhibitor RY103 Suppresses Trp-GCN2-Mediated Angiogenesis and Counters Immunosuppression in Glioblastoma

Glioma is characterized by strong immunosuppression and excessive angiogenesis. Based on existing reports, it can be speculated that the resistance to anti-angiogenic drug vascular endothelial growth factor A (VEGFA) antibody correlates to the induction of novel immune checkpoint indoleamine 2,3-dio...

Полное описание

Библиографические подробности
Главные авторы:	Zikang Xing, Xuewen Li, Zhen Ning Tony He, Xin Fang, Heng Liang, Chunxiang Kuang, Aiying Li, Qing Yang
Формат:	Статья
Язык:	English
Опубликовано:	MDPI AG 2024-06-01
Серии:	Pharmaceutics
Предметы:	glioma angiogenesis indoleamine 2,3-dioxygenase 1 tryptophan depletion general control nonderepressible 2
Online-ссылка:	https://www.mdpi.com/1999-4923/16/7/870

Схожие документы

TRYPTOPHAN AND INDOLEAMINE-2,3-DIOXYGENASE (IDO) IN PATHOGENESIS OF IMMUNOSUPPRESSIVE CLINICAL CONDITIONS
по: V. A. Kozlov, и др.
Опубликовано: (2017-07-01)

On the nonredundant roles of TDO2 and IDO1
по: Paolo ePuccetti
Опубликовано: (2014-10-01)

Activities of plasma indoleamine-2, 3-dioxygenase (IDO) enzyme in Nigerian patients with lung diseases: basis for tryptophan supplementation or IDO inhibitor use
по: Ganiyu Olatunbosun Arinola, и др.
Опубликовано: (2023-01-01)

The Two Sides of Indoleamine 2,3-Dioxygenase 2 (IDO2)
по: Chiara Suvieri, и др.
Опубликовано: (2024-11-01)

What is the prospect of indoleamine 2,3-dioxygenase 1 inhibition in cancer? Extrapolation from the past
по: Yu Yao, и др.
Опубликовано: (2021-02-01)

Tryptophan-degrading enzymes in tumoral immune resistance
по: Nicolas van Baren, и др.
Опубликовано: (2016-11-01)

Association of Indoleamine 2,3-Dioxygenase (IDO) Activity with Outcome after Cardiac Surgery in Adult Patients
по: Andrea Stieger, и др.
Опубликовано: (2024-06-01)

Targeting Indoleamine Dioxygenase and Tryptophan Dioxygenase in Cancer Immunotherapy: Clinical Progress and Challenges
по: Peng X, и др.
Опубликовано: (2022-08-01)

Serum neopterin concentrations and tryptophan degradation pattern in patients with late stage larynx carcinoma
по: Engin Ayse Basak, и др.
Опубликовано: (2017-08-01)

Indoleamine 2,3-dioxygenase (IDO): Only an enzyme or a checkpoint controller?
по: Cemil Bilir, M.D., и др.
Опубликовано: (2017-07-01)

Kynurenines as a Novel Target for the Treatment of Inflammatory Disorders
по: Adrian Mor, и др.
Опубликовано: (2024-07-01)

The catalytic inhibitor epacadostat can affect the non-enzymatic function of IDO1
по: Eleonora Panfili, и др.
Опубликовано: (2023-04-01)

Design, Synthesis and Biological Evaluation of Phenyl Urea Derivatives as IDO1 Inhibitors
по: Chuan Zhou, и др.
Опубликовано: (2020-03-01)

Tumor Microenvironment‐Responsive Nanoparticles Enhance IDO1 Blockade Immunotherapy by Remodeling Metabolic Immunosuppression
по: Mengna Wang, и др.
Опубликовано: (2025-02-01)

Pharmacological Targets of Kaempferol Within Inflammatory Pathways—A Hint Towards the Central Role of Tryptophan Metabolism
по: Stefanie Hofer, и др.
Опубликовано: (2020-02-01)

Targeting Tryptophan Catabolism in Cancer Immunotherapy Era: Challenges and Perspectives
по: Florent Peyraud, и др.
Опубликовано: (2022-01-01)

The Potential Role of Cannabinoids in Modulating Serotonergic Signaling by Their Influence on Tryptophan Metabolism
по: Dietmar Fuchs, и др.
Опубликовано: (2010-08-01)

In vitro Effects of Nigella sativa Seeds Extracts on Stimulated Peripheral Blood Mononuclear Cells
по: Winkler Christiana, и др.
Опубликовано: (2008-02-01)

The Coevolution of IDO1 and AhR in the Emergence of Regulatory T Cells in Mammals
по: Ursula eGrohmann, и др.
Опубликовано: (2015-02-01)

Systemic tryptophan homeostasis
по: Simon Klaessens, и др.
Опубликовано: (2022-09-01)

DSS-induced colitis activates the kynurenine pathway in serum and brain by affecting IDO-1 and gut microbiota
по: Li-Ping Zhao, и др.
Опубликовано: (2023-01-01)

1-MT inhibits the invasion of CBP-resistant ovarian cancer cells via down-regulating IDO expression and re-activating immune cells function
по: Huihan Ma, и др.
Опубликовано: (2020-09-01)

Increased Indoleamine 2,3-Dioxygenase 1 (IDO-1) Activity and Inflammatory Responses during Chikungunya Virus Infection
по: Thiara Manuele Alves de Souza, и др.
Опубликовано: (2022-04-01)

Indoleamine 2,3-Dioxygenase as a Therapeutic Target for Alzheimer’s Disease and Geriatric Depression
по: Karl Savonije, и др.
Опубликовано: (2023-05-01)

An exploratory study of neopterin and kynurenine pathway in pterygium
по: Kilicarslan Bilge, и др.
Опубликовано: (2019-08-01)

Indoleamine 2,3-Dioxygenase Expression Pattern in the Tumor Microenvironment Predicts Clinical Outcome in Early Stage Cervical Cancer
по: A. Marijne Heeren, и др.
Опубликовано: (2018-07-01)

Nattokinase mitigated dextran sulfate sodium-induced chronic colitis by regulating microbiota and suppressing tryptophan metabolism via inhibiting IDO-1
по: Lvqi Zhou, и др.
Опубликовано: (2020-12-01)

IDO Inhibitor and Gallic Acid Cross-Linked Small Molecule Drug Synergistic Treatment of Melanoma
по: Hongmei Liu, и др.
Опубликовано: (2022-07-01)

Tryptophan catabolism increases in breast cancer patients compared to healthy controls without affecting the cancer outcome or response to chemotherapy
по: Concetta Elisa Onesti, и др.
Опубликовано: (2019-07-01)

Biological and clinical significance of tryptophan-catabolizing enzymes in cutaneous T-cell lymphomas
по: Pilvi Maliniemi, и др.
Опубликовано: (2017-03-01)

Combination of IDO inhibitors and platinum(IV) prodrugs reverses low immune responses to enhance cancer chemotherapy and immunotherapy for osteosarcoma
по: Dongquan Xiang, и др.
Опубликовано: (2023-06-01)

Kynurenines as a Novel Target for the Treatment of Malignancies
по: Adrian Mor, и др.
Опубликовано: (2021-06-01)

The Role of Indoleamine 2, 3-Dioxygenase in Immune Suppression and Autoimmunity
по: Jacques C. Mbongue, и др.
Опубликовано: (2015-09-01)

The role of tryptophan in Chlamydia trachomatis persistence
по: Li Wang, и др.
Опубликовано: (2022-08-01)

Design and Synthesis of Indoleamine 2,3-Dioxygenase 1 Inhibitors and Evaluation of Their Use as Anti-Tumor Agents
по: Hui Wen, и др.
Опубликовано: (2019-06-01)

Tryptophan Breakdown in Patients with HCV Infection is Influenced by IL28B Polymorphism
по: Heinz Zoller, и др.
Опубликовано: (2015-06-01)

The IDO Metabolic Trap Hypothesis for the Etiology of ME/CFS
по: Alex A. Kashi, и др.
Опубликовано: (2019-07-01)

Tryptophan feeding of the IDO1-AhR axis in host-microbial symbioses
по: Teresa eZelante, и др.
Опубликовано: (2014-12-01)

Corrigendum: MicroRNA-153 decreases tryptophan catabolism and inhibits angiogenesis in bladder cancer by targeting indoleamine 2,3-dioxygenase 1
по: Wentao Zhang, и др.
Опубликовано: (2023-05-01)

Dexamethasone Induces the Expression and Function of Tryptophan-2-3-Dioxygenase in SK-MEL-28 Melanoma Cells
по: Marta Cecchi, и др.
Опубликовано: (2021-03-01)